Publication:
Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8

dc.contributor.authorRithea Leangen_US
dc.contributor.authorNaw Htee Khuen_US
dc.contributor.authorMavuto Mukakaen_US
dc.contributor.authorMark Debackereen_US
dc.contributor.authorRupam Tripuraen_US
dc.contributor.authorSoy Ty Kheangen_US
dc.contributor.authorSay Chyen_US
dc.contributor.authorNeeraj Kaken_US
dc.contributor.authorPhilippe Buchyen_US
dc.contributor.authorArnaud Tarantolaen_US
dc.contributor.authorDidier Menarden_US
dc.contributor.authorArantxa Roca-Feltereren_US
dc.contributor.authorRick M. Fairhursten_US
dc.contributor.authorSim Khengen_US
dc.contributor.authorSinoun Muthen_US
dc.contributor.authorSong Ngaken_US
dc.contributor.authorArjen M. Dondorpen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorWalter Robert John Tayloren_US
dc.contributor.otherNational Center for Parasitologyen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherMSF Belgium Cambodia Malaria Programen_US
dc.contributor.otherUniversity Research Co., LLCen_US
dc.contributor.otherUniversity Research Co., LLCen_US
dc.contributor.otherInstitut Pasteur du Cambodgeen_US
dc.contributor.otherMalaria Consortiumen_US
dc.contributor.otherNational Institute of Allergy and Infectious Diseasesen_US
dc.contributor.otherFHI 360 Cambodia Officeen_US
dc.contributor.otherHôpitaux universitaires de Genèveen_US
dc.date.accessioned2018-12-11T03:13:54Z
dc.date.accessioned2019-03-14T08:01:52Z
dc.date.available2018-12-11T03:13:54Z
dc.date.available2019-03-14T08:01:52Z
dc.date.issued2016-12-20en_US
dc.description.abstract© 2016 The Author(s). After publication of the original article [1], it came to the authors' attention that there was an error in the PQ pharmacokinetics sub-section of the Background section. The following sentence is affected: "There is no PK interaction between PQ and either artesunate-pyronaridine [76] or mefloquine [69, 77]; no PK interaction data exist for PQ and artemetherlumefantrine (AL)." This sentence should have read as follows: "AS pyronaridine increased PQ exposure by 15% without affecting significantly cPQ exposure [76]. There is no PK interaction between PQ and mefloquine [69, 77]; no PK interaction data exist for PQ and artemetherlumefantrine (AL).".en_US
dc.identifier.citationBMC Medicine. Vol.14, No.1 (2016)en_US
dc.identifier.doi10.1186/s12916-016-0765-5en_US
dc.identifier.issn17417015en_US
dc.identifier.other2-s2.0-85006757133en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/40936
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006757133&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleErratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8en_US
dc.typeErratumen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006757133&origin=inwarden_US

Files

Collections